Update Profiles if Patients Get the Specialty Med Xenleta

Xenleta (zen-LEH-tah, lefamulin) will be a new antibiotic for community-acquired pneumonia.

Xenleta will be touted to cover resistant infections...since it works differently than other antibiotics (azithromycin, etc).

It'll also be promoted to reduce hospital stays...since patients can start with the IV form and finish with oral tabs.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote